Efficacy and safety of Brentuximab Vedotin in advanced cutaneous T-Cell lymphomas patients

被引:1
作者
Papadavid, E. [1 ]
Kapniari, E. [1 ]
Marinos, L. [2 ]
Nikolaou, V. [3 ]
Oikonomidi, A. [3 ]
Georgakopoulos, J. [4 ]
Stratigos, A. [3 ]
Kouloulias, V. [4 ]
Pappa, V. [5 ]
机构
[1] Univ Athens, Dept Dermatol Venereol 2, Attikon Gen Univ Hosp, Athens, Greece
[2] Evaggelismos Gen Hosp, Hemato Pathol Dept, Athens, Greece
[3] Univ Athens, Syggros Hosp, Dept Dermatol Venereol 1, Athens, Greece
[4] Univ Athens, Attikon Gen Univ Hosp, Dept Radiol 2, Radiol Oncol, Athens, Greece
[5] Univ Athens, Attikon Gen Univ Hosp, Propedeut Dept 2, Hematol Unit, Athens, Greece
关键词
MYCOSIS-FUNGOIDES;
D O I
10.1111/jdv.15409
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:E223 / E225
页数:4
相关论文
共 5 条
  • [1] The European Medicines Agency Review of Brentuximab Vedotin (Adcetris) for the Treatment of Adult Patients With Relapsed or Refractory CD30+Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma: Summary of the Scientific Assessment of the Committee for Medicinal Product for Human Use
    Gravanis, Iordanis
    Tzogani, Kyriaki
    van Hennik, Paula
    de Graeff, Pieter
    Schmitt, Petra
    Mueller-Berghaus, Jan
    Salmonson, Tomas
    Gisselbrecht, Christian
    Laane, Edward
    Bergmann, Lothar
    Pignatti, Francesco
    [J]. ONCOLOGIST, 2016, 21 (01) : 102 - 109
  • [2] Updated combined analysis of two phase II studies of brentuximab vedotin in patients with mycosis fungoides and Sezary syndrome
    Huen, Auris
    Rahbar, Z.
    Talpur, R.
    Li, S.
    Hong, E. K.
    Tetzlaff, M.
    Duvic, M.
    Kim, Y. H.
    [J]. EUROPEAN JOURNAL OF CANCER, 2018, 101 : S37 - S37
  • [3] Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
    Prince, H. Miles
    Kim, Youn H.
    Horwitz, Steven M.
    Dummer, Reinhard
    Scarisbrick, Julia
    Quaglino, Pietro
    Zinzani, Pier Luigi
    Wolter, Pascal
    Sanches, Jose A.
    Ortiz-Romero, Pablo L.
    Akilov, Oleg E.
    Geskin, Larisa
    Trotman, Judith
    Taylor, Kerry
    Dalle, Stephane
    Weichenthal, Michael
    Walewski, Jan
    Fisher, David
    Dreno, Brigitte
    Stadler, Rudolf
    Feldman, Tatyana
    Kuzel, Timothy M.
    Wang, Yinghui
    Palanca-Wessels, Maria Corinna
    Zagadailov, Erin
    Trepicchio, William L.
    Zhang, Wenwen
    Lin, Hui-Min
    Liu, Yi
    Huebner, Dirk
    Little, Meredith
    Whittaker, Sean
    Duvic, Madeleine
    [J]. LANCET, 2017, 390 (10094) : 555 - 566
  • [4] Brentuximab vedotin therapy for CD30-positive cutaneous T-cell lymphoma: a targeted approach to management
    Scarisbrick, Julia J.
    [J]. FUTURE ONCOLOGY, 2017, 13 (27) : 2405 - 2411
  • [5] Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sezary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model
    Scarisbrick, Julia J.
    Prince, H. Miles
    Vermeer, Maarten H.
    Quaglino, Pietro
    Horwitz, Steven
    Porcu, Pierluigi
    Stadler, Rudolf
    Wood, Gary S.
    Beylot-Barry, Marie
    Pham-Ledard, Anne
    Foss, Francine
    Girardi, Michael
    Bagot, Martine
    Michel, Laurence
    Battistella, Maxime
    Guitart, Joan
    Kuzel, Timothy M.
    Martinez-Escala, Maria Estela
    Estrach, Teresa
    Papadavid, Evangelia
    Antoniou, Christina
    Rigopoulos, Dimitis
    Nikolaou, Vassilki
    Sugaya, Makoto
    Miyagaki, Tomomitsu
    Gniadecki, Robert
    Sanches, Jose Antonio
    Cury-Martins, Jade
    Miyashiro, Denis
    Servitje, Octavio
    Muniesa, Cristina
    Berti, Emilio
    Onida, Francesco
    Corti, Laura
    Hodak, Emilia
    Amitay-Laish, Iris
    Ortiz-Romero, Pablo L.
    Rodriguez-Peralto, Jose L.
    Knobler, Robert
    Porkert, Stefanie
    Bauer, Wolfgang
    Pimpinelli, Nicola
    Grandi, Vieri
    Cowan, Richard
    Rook, Alain
    Kim, Ellen
    Pileri, Alessandro
    Patrizi, Annalisa
    Pujol, Ramon M.
    Wong, Henry
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (32) : 3766 - 3773